| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.18 |
0.0001 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0006 |